The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Millie Long
Medicine-Gastroenterology
Clinical or Medical
Interventional
Stomach, Digestion and Gut Health
24-2369
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
